'Miss­ing link': Bay­er, Morn­ing­side help cat­a­pult a new kind of de­liv­ery tech to cell and gene ther­a­py

Robert Mill­man co-found­ed and led Sem­ma Ther­a­peu­tics as CEO while al­so a man­ag­ing di­rec­tor of MPM Cap­i­tal. By the time he left the stem cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.